| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/18/2013 | US20130095057 Compounds for the treatment of clostridium difficile-associated disease |
| 04/18/2013 | US20130095053 Regulation of skin pigmentation by neuregulin-1 (nrg-1) |
| 04/18/2013 | US20130095034 Anti-CD74 Immunoconjugates and Methods |
| 04/18/2013 | US20130095033 Multivalent Antibody Complexes Targeting IGF-1R Show Potent Toxicity Against Solid Tumors |
| 04/18/2013 | DE19714913B4 Verfahren zur Herstellung patientenspezifischer Immunadsorber Process for the preparation of patient-specific immuno |
| 04/18/2013 | DE112011102356T5 Pharmazeutische Kombinationszusammensetzung und Verfahren zur Behandlung von Erkrankungen oder Zuständen, die mit dem Herz-Kreislauf-System in Verbindung stehen A pharmaceutical combination compositions and methods for treating diseases or conditions associated with the cardiovascular system |
| 04/18/2013 | DE102011054413A1 Monoklonaler anti-Idiotyp-Antikörper Ganglidiomab Monoclonal anti-idiotype antibody Ganglidiomab |
| 04/18/2013 | DE102004004043B4 Reinigung von hochmolekularen Verbindungen mittels Affinitätsmembranchromatographie Purification of high molecular weight compounds by means of affinity membrane chromatography |
| 04/18/2013 | CA2852099A1 Meditopes and meditope-binding antibodies and uses thereof |
| 04/18/2013 | CA2851917A1 Self-assembling peptide nanoparticles as vaccines against infection with norovirus |
| 04/18/2013 | CA2851814A1 Antibody polypeptides that antagonize cd40l |
| 04/18/2013 | CA2851805A1 Use of semaphorin-4d binding molecules for modulation of blood brain barrier permeability |
| 04/18/2013 | CA2851762A1 Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam) |
| 04/18/2013 | CA2851751A1 Compositions for the treatment of rheumatoid arthritis and methods of using same |
| 04/18/2013 | CA2851284A1 Treatment of breast cancer with companion diagnostic |
| 04/18/2013 | CA2850961A1 Antibodies to cd1d |
| 04/18/2013 | CA2850836A1 Methods of using scd1 antagonists |
| 04/18/2013 | CA2850830A1 Methods for treating vascular leak syndrome and cancer |
| 04/18/2013 | CA2850824A1 Treatment of ocular disease |
| 04/18/2013 | CA2850575A1 Combination medicament comprising il-12 and an agent for blockade of t-cell inhibitory molecules for tumour therapy |
| 04/18/2013 | CA2850032A1 Anti-htra1 antibodies and methods of use |
| 04/18/2013 | CA2848658A1 Vaccines for human papilloma virus and methods for using the same |
| 04/18/2013 | CA2846486A1 Novel clostridium difficile dna vaccine |
| 04/18/2013 | CA2841852A1 Cross-protective arenavirus vaccines and their method of use |
| 04/17/2013 | EP2581450A2 Non-natural amino acid substituted polypeptides |
| 04/17/2013 | EP2581445A1 Regulators of MMP-9 and uses thereof |
| 04/17/2013 | EP2581387A1 An anti-HIV-1 Tat monoclonal antibody |
| 04/17/2013 | EP2581113A1 Anti-tim-3 antibody |
| 04/17/2013 | EP2581094A2 Composition for inhibiting hyperlipidemia and obesity by inhibiting intestinal absorption of cholesterol |
| 04/17/2013 | EP2581093A1 Influenza hemagglutinin and neuraminidase variants |
| 04/17/2013 | EP2581083A1 Methods of treating hematologic cancers using pnp inhibitors such as forodesine in combination with alkylating agents or anti-cd20 agents |
| 04/17/2013 | EP2580240A1 S100a4 antibodies and therapeutic uses thereof |
| 04/17/2013 | EP2580226A1 Trisaccharide derivates, and their use as adjuvants |
| 04/17/2013 | EP2579901A2 Vaccine and methods to reduce campylobacter infection |
| 04/17/2013 | EP2579895A1 Anti-vegf antibodies and uses thereof |
| 04/17/2013 | EP2579894A1 Cgrp antibodies |
| 04/17/2013 | EP2579893A2 Multivalent glycopeptide constructs and uses thereof |
| 04/17/2013 | EP2579892A2 Therapeutic immunization in hiv infected subjects receiving stable antiretroviral treatment |
| 04/17/2013 | EP2579884A1 Anti-tumor composition |
| 04/17/2013 | EP2579850A1 Novel process |
| 04/17/2013 | EP2579849A1 Novel process |
| 04/17/2013 | EP1970074A9 Immune adjuvant |
| 04/17/2013 | CN1911445B Grippe primary generation susliks kidney cell multivalent vaccine and its preparation method |
| 04/17/2013 | CN1604788B High-concentration protein formulations and method of manufacture |
| 04/17/2013 | CN103052404A Neuropilin as a biomarker for bevacizumab combination therapies |
| 04/17/2013 | CN103052403A Treating Disorders Associated With IL-20 Receptor-mediated Signaling Pathway By Blocking IL-20 Receptor Activity |
| 04/17/2013 | CN103052402A 免疫原性组合物 Immunogenic composition |
| 04/17/2013 | CN103052401A 流感疫苗 Influenza vaccination |
| 04/17/2013 | CN103052400A Virion-like delivery particles for self-replicating RNA molecules |
| 04/17/2013 | CN103052399A Method for reducing DNA impurities in viral compositions |
| 04/17/2013 | CN103045630A Encephalitis virus protein and encoding gene and application thereof |
| 04/17/2013 | CN103045614A Mutant phage E gene, punching plasmid vector containing the gene and application thereof in preparation of vaccine |
| 04/17/2013 | CN103045545A Encephalitis virus protein, and coding gene and application thereof |
| 04/17/2013 | CN103045544A Recombinant pseudotyped baculovirus Bac-G-prM/E for preventing West Nile virus as well as vaccine and application thereof |
| 04/17/2013 | CN103044554A Human urinary trypsin inhibitor (hUTI) of reorganization-dimerization and preparation method and application thereof |
| 04/17/2013 | CN103044551A Monoclonal antibody for preventing and treating spontaneous abortion and application thereof |
| 04/17/2013 | CN103044550A IL-31 monoclonal antibodies and methods of use |
| 04/17/2013 | CN103044547A Anti-humanized multidrug resistant protein Fab antibody and preparation method thereof |
| 04/17/2013 | CN103044543A Production method and application of immune globulin G |
| 04/17/2013 | CN103044530A Improved flagellin serving as immunologic adjuvant, and preparation method and application of improved flagellin |
| 04/17/2013 | CN103041404A Preparation method of fish iridovirus DNA (Deoxyribonucleic Acid) vaccine |
| 04/17/2013 | CN103041399A Heat-resisting protective agent and application thereof |
| 04/17/2013 | CN103041388A Piglet colibacillosis egg yolk immunoglobulin biological preparation and preparation process thereof |
| 04/17/2013 | CN103041387A New application of malignant B-cell lymphoma antibody medicament |
| 04/17/2013 | CN103041386A Application of vibrio anguillarum recombinant protein |
| 04/17/2013 | CN103041385A Porcine transmissible gastroenteritis and epidemic diarrhea combined live vaccine and preparation method thereof |
| 04/17/2013 | CN103041384A Vaccine composition as well as preparation method and application thereof |
| 04/17/2013 | CN103041383A Heatproof freeze-drying protective agent of live vaccine, live vaccine freeze-drying powder and preparation method and preparation method of live vaccine freeze-drying powder |
| 04/17/2013 | CN103041382A Echinococcus granulosus recombinant BCG vaccine and preparation method thereof |
| 04/17/2013 | CN103041381A Recombinant inhibin vaccine and preparation method and application of recombinant inhibin vaccine |
| 04/17/2013 | CN103040736A 7S soybean antigen protein injection and preparation method thereof |
| 04/17/2013 | CN103040732A Immunoglobulin formulation and method of preparation thereof |
| 04/17/2013 | CN102533676B Virus recombinant vaccine A-NDV-LX/14 for newcastle disease and construction method thereof |
| 04/17/2013 | CN102443053B Application of using streptococcus suis type-2 hy0245 gene encoded proteins as protective antigens |
| 04/17/2013 | CN102430126B Heat-resistant stabilizer for tissue fluid lyophilization, as well as preparation method and application thereof |
| 04/17/2013 | CN102397541B Preparation method for microencapsulated oral live vaccine of gosling plague |
| 04/17/2013 | CN102337248B Recombinant baby hamster kidney (BHK) cell line capable of expressing encephalitis B virus PrM/M-E protein and application thereof |
| 04/17/2013 | CN102335440B Two gene vaccines containing different CpG (cytidine-phosphatte-guanonine) sequences PCV2 (porcine circovirus 2)-ORF2 and preparation process thereof |
| 04/17/2013 | CN102321547B Recombination yeast engineering bacteria expressing reticuloendotheliosis virus (REV) Gp90 protein, its construction method and application |
| 04/17/2013 | CN102277374B Preparation and application of genetic engineering subunit vaccine for infectious bursal disease |
| 04/17/2013 | CN102250239B Protein capable of combining with vp60 protein of rabbit hemorrhagic disease virus and use thereof |
| 04/17/2013 | CN102233128B Use of p75neurotrophin receptor-extracellular domain (p75NTR-ECD) in medicine for preventing and treating Alzheimer disease |
| 04/17/2013 | CN102205123B Preparation method of yolk antibody sustained-release preparation for preventing gosling plague |
| 04/17/2013 | CN102199210B Anti-interleukin-8 antibody |
| 04/17/2013 | CN102199209B Anti-interleukin-8 antibody |
| 04/17/2013 | CN102174089B Avian influenza virus head protein as well as preparation method and application thereof |
| 04/17/2013 | CN101921323B Human protein (ribosomal protein S20) and use thereof in diagnosis of autoimmune hepatitis |
| 04/17/2013 | CN101883585B A powerful vaccine composition comprising a lipopeptide and poly I:C as an adjuvant |
| 04/17/2013 | CN101851631B Codon-optimized EV71 VP1 gene and nucleic acid vaccine |
| 04/17/2013 | CN101821392B RNA sequence motifs in the context of defined inter-nucleotide linkages inducing specific immune modulatory profiles |
| 04/17/2013 | CN101687021B Uses of monoclonal antibody 8H9 |
| 04/17/2013 | CN101613401B Nucleic acid enzyme surface protein of streptococcus suis 2-type and preparation method and application thereof |
| 04/17/2013 | CN101548008B Preparation of inactivated artificial antigen presenting cells and their use in cell therapies |
| 04/17/2013 | CN101466732B Collagen type IV-like immunoreactive peptide |
| 04/17/2013 | CN101433715B Modified chimeric polypeptides with improved pharmacokinetic properties |
| 04/17/2013 | CN101420983B Methods and compositions comprising supramolecular constructs |
| 04/17/2013 | CN101371923B BAFF receptor (BCMA), an immunoregulatory agent |
| 04/17/2013 | CN101365487B Method for treating joint damage |
| 04/17/2013 | CN101289510B 抗cd40单克隆抗体 Monoclonal antibody anti-cd40 |
| 04/17/2013 | CN101146550B Use of immunogenicity composition in preparing kit for initiating and enhancing immune responses |